These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36277464)

  • 21. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
    King JM; Muthian G; Mackey V; Smith M; Charlton C
    Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
    Taylor TN; Potgieter D; Anwar S; Senior SL; Janezic S; Threlfell S; Ryan B; Parkkinen L; Deltheil T; Cioroch M; Livieratos A; Oliver PL; Jennings KA; Davies KE; Ansorge O; Bannerman DM; Cragg SJ; Wade-Martins R
    Neurobiol Dis; 2014 Feb; 62():193-207. PubMed ID: 24121116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitic Acid-Enriched Diet Increases α-Synuclein and Tyrosine Hydroxylase Expression Levels in the Mouse Brain.
    Schommer J; Marwarha G; Nagamoto-Combs K; Ghribi O
    Front Neurosci; 2018; 12():552. PubMed ID: 30127714
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible changes in the accumulation and activities of tyrosine hydroxylase and dopamine-beta-hydroxylase in neurons of nucleus locus coeruleus during the retrograde reaction.
    Ross RA; Joh TH; Reis DJ
    Brain Res; 1975 Jul; 92(1):57-72. PubMed ID: 240484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
    Perez RG; Hastings TG
    J Neurochem; 2004 Jun; 89(6):1318-24. PubMed ID: 15189334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia.
    Kawahata I; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
    Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
    Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-dopaminergic neurons expressing dopamine synthesis enzymes: differentiation and functional significance.
    Ugryumov MV; Mel'nikova VI; Ershov PV; Balan IS; Kalas A
    Neurosci Behav Physiol; 2002; 32(3):299-307. PubMed ID: 12135344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional distribution and control of tyrosine hydroxylase activity in the quail brain.
    Baillien M; Foidart A; Balthazart J
    Brain Res Bull; 1999 Jan; 48(1):31-7. PubMed ID: 10210165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A site-specific mutation of tyrosine hydroxylase reduces feedback inhibition by dopamine in genetically modified cells grafted in parkinsonian rats.
    Chang JW; Lee WY; Milstien S; Kang UJ
    J Neurochem; 2002 Oct; 83(1):141-9. PubMed ID: 12358737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification by nano-LC-MS/MS of NT5DC2 as a protein binding to tyrosine hydroxylase: Down-regulation of NT5DC2 by siRNA increases catecholamine synthesis in PC12D cells.
    Nakashima A; Yamaguchi H; Kodani Y; Kaneko YS; Kawata M; Nagasaki H; Nagatsu T; Ota A
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1060-1065. PubMed ID: 31279527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
    Devos D; Lejeune S; Cormier-Dequaire F; Tahiri K; Charbonnier-Beaupel F; Rouaix N; Duhamel A; Sablonnière B; Bonnet AM; Bonnet C; Zahr N; Costentin J; Vidailhet M; Corvol JC
    Parkinsonism Relat Disord; 2014 Feb; 20(2):170-5. PubMed ID: 24216088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of tyrosine hydroxylase and dopamine beta-hydroxylase induction in organ cultures of rat sympathetic ganglia by potassium depolarization and cholinomimetics.
    Otten U; Thoenen H
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):153-9. PubMed ID: 7752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.
    Nakashima A; Hayashi N; Kaneko YS; Mori K; Sabban EL; Nagatsu T; Ota A
    J Neural Transm (Vienna); 2009 Nov; 116(11):1355-62. PubMed ID: 19396395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson's disease.
    Fang X; Yuan M; Zhao F; Yu A; Lin Q; Li S; Li H; Wang X; Yu Y; Wang X; Lin Q; Lu C; Yang H
    Nat Commun; 2023 May; 14(1):2661. PubMed ID: 37160866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines.
    Bräutigam M; Kittner B; Herken H
    Arzneimittelforschung; 1985; 35(1A):277-84. PubMed ID: 2859029
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.